http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2224487-C1
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate | 2002-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e14fc3b5ba5bf6a49ff051ccb6dfcf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bfe6ba1f92ce34f1a87c2a87cae9274 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf9fa2d7bfdc9f9f67b5bed120121086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb33858b8f1434f39201d65e6957cca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa4b857eceb4ecfa1135b8d6628be29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8c5d7a181d48c4f7c3799c124c51f8 |
publicationDate | 2004-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2224487-C1 |
titleOfInvention | Surgical method for treating the cases of amotio retinae aggravated with proliferating vitreoretinopathy |
abstract | FIELD: medicine. SUBSTANCE: method involves injecting 0.1 ml of isotonic NaCl solution containing 1000 MU of recombinant prourokinase via pierce in tunics 4 mm distant from limb into vitreous body cavity at least 24 h before surgical intervention. Subtotal vitrectomy is carried out according to standard method. 0.1 ml of solution containing 1 mg of 5-fluoruracyl is injected via sclerotomy hole. The vitreous body cavity is filled silicon oil or air-and-gas mixture. EFFECT: stopped or hold proliferating vitreoretinopathy progress. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2484795-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2716484-C1 |
priorityDate | 2002-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.